Skip to content
Menu

AREV Life Sciences Global Corp. AREVF

Full chart Compare
Set alert

Price alert · AREVF

All alert types
0.00 USD 0.00 (+0.00%)

Regular-session close

0.01 Day range 0.01
0.0005 52-week range 0.01
YTD
0.00%
1 year
-95.00%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

-128.23 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.3×
P/S 67.6×
P/B -3.5×
P/FCF -9.1×
EV/EBITDA -2.6×
EV/Sales 68.2×
FCF Yield -11.0%

Profitability

Gross Margin 59.3%
Operating Margin -2827.7%
Net Margin -2940.4%
ROE 151.6%
ROIC 150.3%
ROA -571.6%

Growth (YoY)

Revenue -80.7%
Operating Income 7.2%
EPS (diluted) 4.0%
Free Cash Flow 75.3%

Financial Health

Current Ratio 0.1×
Quick Ratio 0.1×
Debt / Equity -0.0×
Net Debt / EBITDA -0.0×
Interest Coverage -228×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2022-12-31